These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25218873)

  • 1. Putative role of monoamines in the antidepressant-like mechanism induced by striatal MT2 blockade.
    Noseda AC; Rodrigues LS; Targa AD; Aurich MF; Vital MA; Da Cunha C; Lima MM
    Behav Brain Res; 2014 Dec; 275():136-45. PubMed ID: 25218873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effects.
    Noseda AC; Targa AD; Rodrigues LS; Aurich MF; Lima MM
    Sleep Sci; 2016; 9(1):47-54. PubMed ID: 27226821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REM sleep deprivation generates cognitive and neurochemical disruptions in the intranigral rotenone model of Parkinson's disease.
    Dos Santos AC; Castro MA; Jose EA; Delattre AM; Dombrowski PA; Da Cunha C; Ferraz AC; Lima MM
    J Neurosci Res; 2013 Nov; 91(11):1508-16. PubMed ID: 23908011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats.
    Bassani TB; Gradowski RW; Zaminelli T; Barbiero JK; Santiago RM; Boschen SL; da Cunha C; Lima MM; Andreatini R; Vital MA
    Brain Res; 2014 Dec; 1593():95-105. PubMed ID: 25301688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
    Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
    Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REM sleep deprivation and dopaminergic D2 receptors modulation increase recognition memory in an animal model of Parkinson's disease.
    Targa ADS; Noseda ACD; Rodrigues LS; Aurich MF; Lima MMS
    Behav Brain Res; 2018 Feb; 339():239-248. PubMed ID: 29128393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
    Saravanan KS; Sindhu KM; Mohanakumar KP
    Brain Res; 2005 Jul; 1049(2):147-55. PubMed ID: 15936733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REM sleep deprivation reverses neurochemical and other depressive-like alterations induced by olfactory bulbectomy.
    Maturana MJ; Pudell C; Targa AD; Rodrigues LS; Noseda AC; Fortes MH; Dos Santos P; Da Cunha C; Zanata SM; Ferraz AC; Lima MM
    Mol Neurobiol; 2015 Feb; 51(1):349-60. PubMed ID: 24826915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory impairment in the rotenone model of Parkinson's disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation.
    Rodrigues LS; Targa AD; Noseda AC; Aurich MF; Da Cunha C; Lima MM
    Front Cell Neurosci; 2014; 8():383. PubMed ID: 25520618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
    Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D₁ and D₂ receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model: effect of serotonin, dopamine and norepinephrine.
    Paul J; Nandhu MS; Kuruvilla KP; Paulose CS
    Neurol Res; 2010 Nov; 32(9):918-24. PubMed ID: 20887679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-like effect of bis-eugenol in the mice forced swimming test: evidence for the involvement of the monoaminergic system.
    do Amaral JF; Silva MI; de Aquino Neto MR; Moura BA; de Carvalho AM; Vasconcelos PF; Barbosa Filho JM; Gutierrez SJ; Vasconcelos SM; Macêdo DS; de Sousa FC
    Fundam Clin Pharmacol; 2013 Oct; 27(5):471-82. PubMed ID: 22827775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT
    Noseda ACD; Rodrigues LS; Targa ADS; Ilkiw JL; Fagotti J; Dos Santos PD; Cecon E; Markus RP; Solimena M; Jockers R; Lima MMS
    Eur J Pharmacol; 2021 Jan; 891():173722. PubMed ID: 33159932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling a new circuitry for sleep regulation in Parkinson's disease.
    Targa AD; Rodrigues LS; Noseda AC; Aurich MF; Andersen ML; Tufik S; da Cunha C; Lima MM
    Neuropharmacology; 2016 Sep; 108():161-71. PubMed ID: 27091486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test.
    Madiha S; Haider S
    Metab Brain Dis; 2019 Feb; 34(1):297-308. PubMed ID: 30506334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats.
    de Oliveira RA; Cunha GM; Borges KD; de Bruin GS; dos Santos-Filho EA; Viana GS; de Bruin VM
    Pharmacol Biochem Behav; 2004 Nov; 79(3):499-506. PubMed ID: 15582021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
    Tapias V; Cannon JR; Greenamyre JT
    J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
    Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
    Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.